rs7521667

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000537.4(REN):​c.373+293C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 152,166 control chromosomes in the GnomAD database, including 1,828 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 1828 hom., cov: 32)

Consequence

REN
NM_000537.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.423

Publications

4 publications found
Variant links:
Genes affected
REN (HGNC:9958): (renin) This gene encodes renin, an aspartic protease that is secreted by the kidneys. Renin is a part of the renin-angiotensin-aldosterone system involved in regulation of blood pressure, and electrolyte balance. This enzyme catalyzes the first step in the activation pathway of angiotensinogen by cleaving angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin I converting enzyme. This cascade can result in aldosterone release, narrowing of blood vessels, and increase in blood pressure as angiotension II is a vasoconstrictive peptide. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause hyperuricemic nephropathy familial juvenile 2, familial hyperproreninemia, and renal tubular dysgenesis. [provided by RefSeq, May 2020]
REN Gene-Disease associations (from GenCC):
  • familial juvenile hyperuricemic nephropathy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-204160999-G-T is Benign according to our data. Variant chr1-204160999-G-T is described in ClinVar as Benign. ClinVar VariationId is 1272972.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RENNM_000537.4 linkc.373+293C>A intron_variant Intron 3 of 9 ENST00000272190.9 NP_000528.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RENENST00000272190.9 linkc.373+293C>A intron_variant Intron 3 of 9 1 NM_000537.4 ENSP00000272190.8
RENENST00000638118.1 linkc.259+293C>A intron_variant Intron 5 of 11 5 ENSP00000490307.1

Frequencies

GnomAD3 genomes
AF:
0.154
AC:
23448
AN:
152048
Hom.:
1822
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.0814
Gnomad SAS
AF:
0.0958
Gnomad FIN
AF:
0.141
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.129
Gnomad OTH
AF:
0.143
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.154
AC:
23469
AN:
152166
Hom.:
1828
Cov.:
32
AF XY:
0.154
AC XY:
11476
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.207
AC:
8594
AN:
41468
American (AMR)
AF:
0.175
AC:
2678
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
575
AN:
3472
East Asian (EAS)
AF:
0.0812
AC:
421
AN:
5186
South Asian (SAS)
AF:
0.0958
AC:
461
AN:
4810
European-Finnish (FIN)
AF:
0.141
AC:
1494
AN:
10612
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.129
AC:
8767
AN:
68012
Other (OTH)
AF:
0.142
AC:
299
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1018
2037
3055
4074
5092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.137
Hom.:
800
Bravo
AF:
0.162
Asia WGS
AF:
0.109
AC:
380
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.049
DANN
Benign
0.70
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7521667; hg19: chr1-204130127; API